Dr. Kibel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
45 Francis St
Asb II
Boston, MA 02115Phone+1 617-525-7697Fax+1 617-525-6348
Education & Training
- Johns Hopkins UniversityFellowship, Minimally Invasive Urologic Surgery, 1997 - 1999
- Brigham and Women's Hospital/Harvard Medical SchoolResidency, Urology, 1993 - 1997
- Brigham and Women's HospitalResidency, Surgery, 1991 - 1993
- Weill Cornell MedicineClass of 1991
Certifications & Licensure
- RI State Medical License 2021 - 2026
- MA State Medical License 1992 - 2025
- ME State Medical License 2020 - 2025
- NH State Medical License 2023 - 2025
- MD State Medical License 1997 - 2000
- American Board of Urology Urology
Awards, Honors, & Recognition
- Boston Magazine Castle Connolly, 2012-2023
- America's Top Doctors Castle Connolly, 2009-2023
- America's Top Doctors for Cancer Castle Connolly, 2005-2023
Clinical Trials
- Observation or Radical Treatment in Patients With Prostate Cancer Start of enrollment: 2007 Dec 06
- Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial Start of enrollment: 2011 Jul 01
Publications & Presentations
PubMed
- 33 citationsCRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer.Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, Fu Gui, Takeshi Tsutsumi
Nature Communications. 2023-01-17 - 27 citationsTargeting the MIF/CXCR7/AKT Signaling Pathway in Castration-Resistant Prostate Cancer.Shahrzad Rafiei, Bin Gui, Jiaxin Wu, X. Shirley Liu, Adam S. Kibel
Molecular Cancer Research. 2019-01-01 - 1358 citationsCell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.Katherine A Hoadley, Christina Yau, Toshinori Hinoue, Denise M. Wolf, Alexander J. Lazar
Cell. 2018-04-05
Journal Articles
- Geographic Distribution of Racial Differences in Prostate Cancer MortalityDavid F Friedlander, Kerry L Kilbridge, Paul L Nguyen, Toni K Choueiri, Adam S Kibel, Quoc-Dien Trinh, JAMA Network Open
- miR-218 Expressed in Endothelial Progenitor Cells Contributes to the Development and Repair of the Kidney MicrovasculatureSteven L Chang, Graeme Steele, Adam S Kibel, Andrew M Siedlecki, The American Journal of Pathology
- Neoadjuvant Androgen Deprivation Therapy Prior to Radical Prostatectomy: Recent Trends in Utilization and Association with Postoperative Surgical Margin StatusPaul L Nguyen, Adam S Kibel, Mani Menon, Sean A Fletcher, Toni K Choueiri, Annals of Surgical Oncology
Authored Content
- Comparative Effectiveness of Robot-Assisted vs. Open Radical Cystectomy☆☆☆December 2017
Press Mentions
- At High Risk of Prostate Cancer? Here’s How to Lower Your OddsJuly 14th, 2022
- Healthy Lifestyle May Offset Genetic Risk of Prostate CancerJuly 11th, 2022
- Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate CancerJune 27th, 2022
- Join now to see all
Grant Support
- The Role of PARP2 in Prostate CancerDepartment of Defense2017–2020
- A selective Androgen Receptor Modulator for Symptom Management in Prostate CancerNational Cancer Center2015–2020
- NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care for ALLIANCE Cooperative Oncology ConsortiumNational Cancer Institute2014–2019
- Dana Farber-Harvard Cancer Center Specialized Program of Research Excellence (SPORE) in Prostate CancerNational Cancer Institute2013–2018
- A multilevel approach to energy balance and cancer across the lifecourseNational Cancer Institute2011–2017
- Hypogonadism and Pain Perception in Androgen-deprived Men with Prostate CancerNational Cancer Institute2013–2016
- Cell Cycle Variants And Metastatic Prostate Cancer RiskNational Cancer Institute2005–2009
- Identification Of A 12p Prostate Tumor Suppressor GeneNational Cancer Institute2001–2006
- Genetic Risk Profiling In Metastatic Prostate CarcinomaNational Cancer Institute2003–2004
Committees
- Vice Chair, Castration-resistant Prostate Cancer Guidelines Panel, AUA 2015 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: